Voriconazole therapeutic drug monitoring: retrospective cohort study of the relationship to clinical outcomes and adverse events

BACKGROUND: Voriconazole is approved for treatment of invasive aspergillosis and other invasive fungal infections, but the role for therapeutic drug monitoring (TDM) is not clear. METHODS: We performed a retrospective cohort study of patients at the University of Washington Medical Center and Fred H...

Descripción completa

Detalles Bibliográficos
Autores principales: Chu, Helen Y, Jain, Rupali, Xie, Hu, Pottinger, Paul, Fredricks, David N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3655856/
https://www.ncbi.nlm.nih.gov/pubmed/23442261
http://dx.doi.org/10.1186/1471-2334-13-105

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3655856/
https://www.ncbi.nlm.nih.gov/pubmed/23442261
http://dx.doi.org/10.1186/1471-2334-13-105

Ejemplares similares